Evidence map›Paper›PMID 9121454›Full record

ArticleMolecular and cellular biology1997

Saccharomyces cerevisiae BUR6 encodes a DRAP1/NC2alpha homolog that has both positive and negative roles in transcription in vivo.

G Prelich

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 88 citations in OpenAlex.

  1. Mot1 regulation of promoter binding by TBP varies with stress and gene expression levels independently of coactivator dependence.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Review
  4. International journal of molecular sciences · 2020
    Article
  5. Article
  6. Article
  7. The General Transcription RepressorFrontiers in genetics · 2019
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. The dynamic personality of TATA-binding protein.Trends in biochemical sciences · 2009
    Article
  17. Regulation of TATA-binding protein dynamics in living yeast cells.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

G PrelichDepartment of Molecular Genetics, Albert Einstein College of Medicine, Bronx, New York 10461, USA. Prelich@aecom.yu.edu
Albert Einstein College of Medicine · US

Funding

GENETIC ANALYSIS OF BASAL TRANSCRIPTION IN YEASTR01GM052486 · NIGMS · YESHIVA UNIVERSITY · PI PRELICH, GREGORY · 1996 to 2009
$3.4M
NIGMS NIH HHS GM52486
6 · The paper itself

Abstract

BUR3 and BUR6 were identified previously by selecting for mutations that increase transcription from an upstream activating sequence (UAS)-less promoter in Saccharomyces cerevisiae. The bur3-1 and bur6-1 mutations are recessive, increase transcription from a suc2 delta uas allele, and cause other mutant phenotypes, suggesting that Bur3p and Bur6p function as general repressors of the basal transcriptional machinery. The molecular cloning and characterization of BUR3 and BUR6 are presented here. BUR3 is identical to MOT1, a previously characterized essential gene that encodes an ATP-dependent inhibitor of the TATA box-binding protein. Cloning and nucleotide sequence analysis reveals that BUR6 encodes a homolog of DRAP1 (also called NC2alpha), a mammalian repressor of basal transcription. Strains that contain a bur6 null allele are viable but grow extremely poorly, demonstrating that BUR6 is critical for normal cell growth in yeast. The Bur6p histone fold domain is required for function; an extensive nonoverlapping set of deletion alleles throughout the histone fold domain impairs BUR6 function in vivo, whereas mutations in the amino- and carboxy-terminal tails have no detectable effect. BUR6 and BUR3/MOT1 have different functions depending on promoter context: although the bur3-1 and bur6-1 mutations increase transcription from delta uas promoters, they result in reduced transcription from the wild-type GAL1 and GAL10 promoters. This transcriptional defect is due to the inability of the GAL10 UAS to function in bur6-1 strains. The similar phenotypes of bur6 and bur3 (mot1) mutations suggest that Bur6p and Mot1p have related, but not identical, functions in modulating the activity of the general transcription machinery in vivo.

Indexed as

Genes, FungalSaccharomyces cerevisiae ProteinsTATA-Binding Protein Associated FactorsAdenosine TriphosphatasesAmino Acid SequenceCloning, MolecularDNA HelicasesFungal ProteinsGenes, ReporterMolecular Sequence DataMutationPhenotypePhosphoproteinsRepressor ProteinsSaccharomyces cerevisiaeSequence Homology, Amino AcidAdenosine TriphosphatasesBUR6 protein, S cerevisiaeDNA Helicasesdown-regulator of transcription 1Fungal ProteinsMOT1 protein, S cerevisiaePhosphoproteinsRepressor ProteinsSaccharomyces cerevisiae ProteinsTATA-Binding Protein Associated FactorsTrans-ActivatorsTranscription Factors

Identifiers

PMID9121454
PMCPMC232053
OpenAlexW2106876088

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.